We are live on
!
Find out more
LCG
Lisanti Capital Growth Portfolio holdings
AUM
$397M
1-Year Est. Return
178.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.1%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$336M
AUM Growth
-$79.5M
(-19%)
Cap. Flow
-$67.7M
Cap. Flow
% of AUM
-20.14%
Top 10 Holdings %
Top 10 Hldgs %
21.14%
Holding
166
New
55
Increased
21
Reduced
32
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palomar
PLMR
|
+$6.86M |
| 2 |
Casella Waste Systems
CWST
|
+$6.85M |
| 3 |
Lantheus
LNTH
|
+$5.39M |
| 4 |
MASI
Masimo
MASI
|
+$5.29M |
| 5 |
RBC Bearings
RBC
|
+$5.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Astera Labs
ALAB
|
+$10.4M |
| 2 |
Comfort Systems
FIX
|
+$8.32M |
| 3 |
Freshpet
FRPT
|
+$7.82M |
| 4 |
Kornit Digital
KRNT
|
+$6.62M |
| 5 |
Semtech
SMTC
|
+$6.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.15% |
| 2 | Technology | 20.29% |
| 3 | Industrials | 19.7% |
| 4 | Consumer Discretionary | 10.19% |
| 5 | Financials | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Corcept Therapeutics
CORT
$12.4B
| $11.4M | 3.38% |
99,460
+21,795
| +28% | +$1.33M |
|
|
2
Palomar
PLMR
$3.55B
| $7.93M | 2.36% |
+57,870
| New | +$6.86M |
|
3
ANI Pharmaceuticals
ANIP
$1.8B
| $7.06M | 2.1% |
105,425
+78,515
| +292% | +$4.69M |
|
|
4
Casella Waste Systems
CWST
$5.71B
| $6.98M | 2.08% |
+62,625
| New | +$6.85M |
|
5
UL Solutions
ULS
$18.5B
| $6.66M | 1.98% |
118,155
+24,535
| +26% | +$1.3M |
|
6
Kratos Defense & Security Solutions
KTOS
$8.74B
| $6.46M | 1.92% |
217,545
-5,815
| -3% | -$176K |
|
7
Commault Systems
CVLT
$4.88B
| $6.37M | 1.9% |
40,400
-2,745
| -6% | -$452K |
|
8
BrightSpring Health Services
BTSG
$11.7B
| $6.21M | 1.85% |
343,015
+11,105
| +3% | +$218K |
|
9
ADMA Biologics
ADMA
$1.96B
| $6.12M | 1.82% |
308,440
+132,970
| +76% | +$2.3M |
|
|
JBTM
10
JBT Marel
JBTM
$7.21B
| $5.9M | 1.75% |
48,265
+820
| +2% | +$104K |
|
11
Ollie's Bargain Outlet
OLLI
$4.44B
| $5.86M | 1.74% |
50,335
-2,220
| -4% | -$235K |
|
|
12
Lantheus
LNTH
$6.49B
| $5.63M | 1.67% |
+57,670
| New | +$5.39M |
|
13
Ligand Pharmaceuticals
LGND
$5.76B
| $5.53M | 1.64% |
52,575
+13,565
| +35% | +$1.53M |
|
14
Krystal Biotech
KRYS
$10.1B
| $5.48M | 1.63% |
+30,410
| New | +$5.12M |
|
15
Applied Industrial Technologies
AIT
$12.8B
| $5.37M | 1.6% |
23,835
+7,345
| +45% | +$1.81M |
|
16
Genius Sports
GENI
$1.85B
| $5.36M | 1.59% |
+535,435
| New | +$4.96M |
|
17
Q2 Holdings
QTWO
$3.8B
| $5.33M | 1.59% |
66,665
-49,135
| -42% | -$4.33M |
|
18
Stride
LRN
$3.41B
| $5.21M | 1.55% |
+41,155
| New | +$5.2M |
|
19
VSE Corp
VSEC
$5.45B
| $5.2M | 1.55% |
43,375
+1,575
| +4% | +$169K |
|
|
MASI
20
DELISTED
Masimo
MASI
| $5.08M | 1.51% |
+30,485
| New | +$5.29M |
|
|
21
RBC Bearings
RBC
$17.4B
| $5M | 1.49% |
+15,550
| New | +$5.24M |
|
22
Sportradar
SRAD
$4.3B
| $4.99M | 1.48% |
+230,640
| New | +$4.81M |
|
23
Construction Partners
ROAD
$5.84B
| $4.96M | 1.47% |
68,960
-36,655
| -35% | -$2.89M |
|
24
Huron Consulting
HURN
$2.41B
| $4.63M | 1.38% |
+32,250
| New | +$4.34M |
|
25
Skyward Specialty Insurance
SKWD
$2.43B
| $4.59M | 1.37% |
86,765
+53,235
| +159% | +$2.56M |
|
Similar funds
GF
PIM
EH
TPWA
ECA
DL
STT
VC
Lisanti Capital Growth's Q1 2025 Portfolio in Review
As of Q1 2025, Lisanti Capital Growth held 166 positions worth $336M, down 19% from $416M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Lisanti Capital Growth withdrew a net $67.7M in Q1 2025, closing 58 positions and reducing 32 holdings. Its most notable exit was Astera Labs, an estimated $10.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
Against the trend, Lisanti Capital Growth opened a new position in Palomar worth $7.93M.
- Lisanti Capital Growth's largest Q1 2025 buy was Palomar: 57,870 shares worth $7.93M.
- Lisanti Capital Growth added most to ANI Pharmaceuticals in Q1 2025, an estimated $4.69M increase.
- Lisanti Capital Growth's biggest Q1 2025 reduction was Xometry, cutting an estimated $4.94M.
- Lisanti Capital Growth fully exited Astera Labs in Q1 2025, selling an estimated $10.4M.
- Lisanti Capital Growth's ten largest holdings make up 21% of its $336M portfolio in Q1 2025.
- Lisanti Capital Growth opened 55 new positions and closed 58 in Q1 2025.
- Lisanti Capital Growth's portfolio value fell 19% quarter-over-quarter to $336M.
Based on Lisanti Capital Growth's 13F filing for Q1 2025, filed 25 Apr 2025.